RandyAlanLiebermanMD
Cardiology • Detroit, MIAdult Congenital Heart Disease, Cardiac Electrophysiology
Professor of Medicine, Wayne State University
Dr. Lieberman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4201 Saint Antoine St Ste 7b
Detroit, MI 48201Phone+1 313-745-0233Fax+1 313-993-0295
Education & Training
Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Cardiovascular Disease, 1988 - 1991
Vanderbilt University Medical CenterInternship, Internal Medicine, 1985 - 1986
Wright State University Boonshoft School of MedicineClass of 1985
Certifications & Licensure
MI State Medical License 1999 - 2027
CA State Medical License 1993 - 2024
OH State Medical License 1988 - 2024- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Clinical Cardiac Electrophysiology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Longitudinal Surveillance Registry (LSR) of ACUITY Spiral Start of enrollment: 2009 Aug 04
- INcrease Of VAgal TonE in CHF Start of enrollment: 2011 Feb 01
Publications & Presentations
PubMed
- 1200 citationsCombined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.James B. Young, William T. Abraham, Andrew L. Smith, Angel R. Leon, Randy Lieberman
JAMA. 2003-05-28 - 238 citationsVagus Nerve Stimulation for the Treatment of Heart Failure: The INOVATE-HF TrialMichael R. Gold, Dirk J. van Veldhuisen, Paul J. Hauptman, Martin Borggrefe, Spencer H. Kubo
Journal of the American College of Cardiology. 2016-07-12 - 365 citationsEffects of Cardiac Resynchronization on Disease Progression in Patients With Left Ventricular Systolic Dysfunction, an Indication for an Implantable Cardioverter-Defib...William T. Abraham, James B. Young, Angel R. Leon, Stuart W. Adler, Alan J. Bank
Circulation. 2004-11-02
Press Mentions
A Look at Major COVID-19 Developments over the Past WeekJuly 3rd, 2021
Medtronic Wins FDA Nod for Next-Gen Linq ICMMarch 13th, 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
